LNA Santé S.A.
LNA.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.69 | -1.09 | 7.28 | 0.10 |
| FCF Yield | 27.60% | 41.16% | 29.30% | 13.69% |
| EV / EBITDA | 7.31 | 7.02 | 7.87 | 10.14 |
| Quality | ||||
| ROIC | 3.42% | 3.16% | 3.11% | 2.62% |
| Gross Margin | 11.29% | 32.75% | 85.47% | 83.81% |
| Cash Conversion Ratio | 3.76 | 4.17 | 3.64 | 3.33 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.47% | 2.20% | 8.26% | 9.31% |
| Free Cash Flow Growth | -15.75% | -5.89% | 36.19% | -50.29% |
| Safety | ||||
| Net Debt / EBITDA | 5.53 | 5.60 | 5.71 | 6.48 |
| Interest Coverage | 2.38 | 2.31 | 3.03 | 2.79 |
| Efficiency | ||||
| Inventory Turnover | 4.00 | 3.34 | 1.08 | 1.30 |
| Cash Conversion Cycle | 87.70 | 89.30 | 156.26 | 135.82 |